Oppenheimer Lowers Sarepta Therapeutics (NASDAQ:SRPT) Price Target to $45.00
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its price target cut by equities research analysts at Oppenheimer from $123.00 to $45.00 in a research note issued on Friday,Benzinga reports. The brokerage presently has an “outperform” rating on the biotechnology company’s stock. Oppenheimer’s price objective suggests a potential upside of 124.10% from the company’s current […]
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its price target cut by equities research analysts at Oppenheimer from $123.00 to $45.00 in a research note issued on Friday,Benzinga reports. The brokerage presently has an “outperform” rating on the biotechnology company’s stock. Oppenheimer’s price objective suggests a potential upside of 124.10% from the company’s current […]
